ClinicalTrials.gov
public full text
Public Domain
Subcuteous Methotrexate in Rheumatoid Arthritis
Methotrexate use is important for the treatment of Rheumatoid arthritis. Some patients can not tolerate oral methotrexate. So subcutaneous may help to overcome it.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of LY2127399 in Rheumatoid Arthritis#1370596
- Methotrexate for Central Serous Chorioretinopathy Treatment Trial#1124935
- ReneuRx™ (Nerve Selective Therapy) Utilized in Lateral Hip Pain#1262222
- Outpatient Administration of High Dose Methotrexate (HD MTX) in Patients With Osteosarcoma#1139844
- Rheumatoid Arthritis Response to Methotrexate#907582
Record · ID 1230073
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive